NECLIFE.NSライブシグナル | Getagraph.comで利益を最大化

Live Chart Being Loaded With Signals

Commentary (8 5月 2024 @ 18:59):

Stats
本日の出来高	874 210
平均出来高	1.35M
時価総額	7.82B
EPS	INR0 ( 2024-02-13 )
次の収益日	( INR0 ) 2024-05-27
Last Dividend	INR0.0500 ( 2020-09-18 )
Next Dividend	INR0 ( N/A )
P/E	96.81
ATR14	INR0.0840 (0.24%)

ボリューム相関

長: -0.07 (neutral)

短: 0.09 (neutral)

Signal:(44.129) Neutral

Nectar Lifesciences 相関

10 最も正の相関

10 最も負の相関

知っていましたか？

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関（1つの変数が増加すると、もう一方は減少する）、1は完全な正の相関（1つの変数が増加すると、もう一方も増加する）、0は相関がないことを示します（変数間に関係がない）。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

Nectar Lifesciences 相関 - 通貨/商品

0.31
( neutral )

-0.64
( weak negative )

0.00
( neutral )

-0.25
( neutral )

-0.03
( neutral )

0.57
( weak )

Nectar Lifesciences 財務諸表

Annual	2022
収益:	INR15.24B
総利益:	INR3.64B (23.91 %)
EPS:	INR-1.080

FY	2022
収益:	INR15.24B
総利益:	INR3.64B (23.91 %)
EPS:	INR-1.080

FY	2022
収益:	INR16.69B
総利益:	INR2.99B (17.94 %)
EPS:	INR1.120

FY	2021
収益:	INR15.43B
総利益:	INR2.58B (16.69 %)
EPS:	INR-3.27

Financial Reports:

No articles found.

Nectar Lifesciences Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)

Nectar Lifesciences Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 1.879 - low (50.00%) | Divividend Growth Potential Score: 2.82 - No dividend growth expected in the near future

Information

First Dividend	INR0.100	2006-02-01
Last Dividend	INR0.0500	2020-09-18
Next Dividend	INR0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	16	--
Total Paid Out	INR1.900	--
Avg. Dividend % Per Year	0.05%	--
Score	1.39	--
Div. Sustainability Score	1.879
Div.Growth Potential Score	2.82
Div. Directional Score	2.35	--

Next Divdend (Est)
(2024-09-10)

INR0 Estimate 0.00 %

Dividend Stability

0.04 Very Bad

Dividend Score

1.39

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield
2006	INR0	0.00%
2007	INR0	0.00%
2008	INR0	0.00%
2009	INR0	0.00%
2010	INR0	0.00%
2011	INR0	0.00%
2012	INR0	0.00%
2013	INR0	0.00%
2014	INR0	0.00%
2015	INR0	0.00%
2016	INR0	0.00%
2017	INR0	0.00%
2018	INR0.0500	0.19%
2019	INR0.0500	0.24%
2020	INR0.100	0.81%
2021	INR0	0.00%
2022	INR0	0.00%
2023	INR0	0.00%
2024	INR0	0.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for NSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
SONATSOFTW.NS	Dividend Knight	2023-07-21	Semi-Annually	23	1.92%
MOLDTECH.NS	Dividend Knight	2023-09-18	Annually	9	1.62%
HEG.NS	Dividend Junior	2023-08-24	Annually	23	1.70%
BHARATRAS.NS	Dividend Junior	2023-09-06	Annually	17	0.01%
RAMAPHO.NS	No Dividend Player	2023-08-10	Annually	3	0.17%
KKCL.NS	Dividend Knight	2023-05-11	Semi-Annually	19	1.67%
ENIL.NS	Dividend Junior	2023-09-15	Annually	12	0.39%
ALICON.NS	Dividend Junior	2023-09-13	Annually	18	0.25%
SUTLEJTEX.NS	Dividend Junior	2023-08-18	Annually	18	1.03%
NDRAUTO.NS	Dividend Junior	2023-07-12	Annually	4	0.59%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.00493	1.500	9.90	10.00	[0 - 0.5]
returnOnAssetsTTM	0	1.200	0	0	[0 - 0.3]
returnOnEquityTTM	0.00754	1.500	-1.027	-1.541	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	0	0.800	-5.00	-4.00	[1 - 3]
quickRatioTTM	0	0.800	-4.71	-3.76	[0.8 - 2.5]
cashRatioTTM	0	1.500	-1.111	-1.667	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	1.093	1.000	-0.706	-0.706	[3 - 30]
operatingCashFlowPerShareTTM	5.43	2.00	8.19	10.00	[0 - 30]
freeCashFlowPerShareTTM	5.43	2.00	7.29	10.00	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	0.251	1.000	9.14	9.14	[0.2 - 0.8]
operatingProfitMarginTTM	0.0553	1.000	-0.893	-0.893	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	0	0.800	-3.33	-2.67	[0.5 - 2]
Total Score				1.879

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	95.26	1.000	0.479	0	[1 - 100]
returnOnEquityTTM	0.00754	2.50	-0.660	-1.541	[0.1 - 1.5]
freeCashFlowPerShareTTM	5.43	2.00	8.19	10.00	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	5.43	2.00	8.19	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	0.710	1.500	8.60	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0746	1.000	-0.635	0	[0.1 - 0.5]
Total Score				2.82

Nectar Lifesciences

Nectar Lifesciences Limited manufactures and sells pharmaceutical products in India and internationally. The company offers contract research and manufacturing services, including process development and optimization, process scale up and validation, preparation and international submission of drug master files and certificates of suitability, multi kilo pilot plant production, bulk production, and chiral resolution; and chemical and analytical development, as well as analytical, manufacturing, and engineering consulting services. Its active pharmaceutical ingredients and intermediates comprise cefixime trihydrate, cefuroxime axetil, cefpodoxime proxetil, cefdinir, ceftriaxone sodium, cefotaxime sodium, cefuroxime sodium, ceftazidime, cefepime HCl, cephalothin, cefazolin sodium, cefprozil, cefoperzone sodium, cefpirome sulphate, and cefoxitin sodium. The company also offers contract manufacturing for finished dosage forms, such as tablets, capsules, dry powder oral suspensions, and granules and injectable for cephalosporins. In addition, it provides a range of diagnostics products; empty hard gelatin capsules; and menthol products. Nectar Lifesciences Limited was incorporated in 1995 and is headquartered in Chandigarh, India.